Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.10
Ask: 19.48
Change: 0.02 (0.10%)
Spread: 0.38 (1.99%)
Open: 18.80
High: 19.94
Low: 18.80
Prev. Close: 19.48
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Welcomes MEPs' Rejection of Cadmium Quantum Dots

20 May 2015 14:31

RNS Number : 8094N
Nanoco Group PLC
20 May 2015
 

 

 

For immediate release

20 May 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Welcomes MEPs' Rejection of Cadmium in Quantum Dots

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, confirms that Members of the European Parliament ("MEPs") have voted against a proposed extension of an exemption to the Restriction of Hazardous Substances Directive (RoHS) which would have allowed the use of cadmium-containing quantum dots in Europe.

 

Nanoco welcomes this decision by MEPs owing to the threat posed by cadmium to human health and to the environment.

 

Michael Edelman, Nanoco's Chief Executive Officer, said: "We are very pleased by this decision by the European Parliament and we would like to thank MEPs for the time they have taken to understand the detail and implications of the proposed exemption.

 

"Cadmium-free quantum dots are without question the preferred choice for human and environmental health. Such quantum dots have significant technological benefits and they are available today. We look forward to their increasingly widespread use throughout Europe, and worldwide, in multiple applications including enhanced LCD displays."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFVESIIFIE
Date   Source Headline
18th Dec 200612:15 pmRNSTotal Voting Rights
14th Dec 20067:01 amRNSResearch Update
12th Dec 20061:32 pmRNSHolding(s) in Company
8th Dec 200611:40 amRNSHolding(s) in Company
4th Dec 20067:01 amRNSResearch Update
1st Dec 20063:06 pmRNSHolding(s) in Company
22nd Nov 200610:00 amRNSHolding(s) in Company
20th Nov 20063:12 pmRNSHolding(s) in Company
16th Nov 20067:00 amRNSResearch Update
14th Nov 20064:09 pmRNSHolding(s) in Company
8th Nov 20069:08 amRNSDirector/PDMR Shareholding
6th Nov 200612:49 pmRNSHolding(s) in Company
2nd Nov 20062:01 pmRNSHolding(s) in Company
31st Oct 20069:47 amRNSHolding(s) in Company
31st Oct 20069:38 amRNSHolding(s) in Company
26th Oct 20067:01 amRNSDirector/PDMR Shareholding
25th Oct 20067:01 amRNSIssue of Equity
12th Oct 20067:00 amRNSRe Agreement
21st Sep 20069:46 amRNSDirector/PDMR Shareholding
18th Sep 200610:24 amRNSHolding(s) in Company
13th Sep 20068:54 amRNSHolding(s) in Company
12th Sep 200612:11 pmRNSHolding(s) in Company
12th Sep 20067:02 amRNSInterim Results
4th Sep 20067:01 amRNSNotice of Results
30th Aug 20062:39 pmRNSHolding(s) in Company
15th Aug 20067:01 amRNSNotice of Interim Results
9th Aug 20062:20 pmRNSHolding(s) in Company
20th Jun 20067:01 amRNSPh II Cataract Trial Starts
13th Jun 20067:00 amRNSPh IIb Hay Fever Trial Starts
24th May 20067:01 amRNSCase Western Collaboration
23rd May 20067:02 amRNSBoard Appointment
16th May 20067:02 amRNSUS Appointment
15th May 20067:04 amRNSConference Webcast
10th May 20064:26 pmRNSHolding(s) in Company
26th Apr 20064:50 pmRNSResult of AGM
4th Apr 20067:01 amRNSMerial Option Agreement
13th Mar 20067:02 amRNSBoston Conference Webcast
1st Mar 20069:27 amRNSDirector/PDMR Shareholding
28th Feb 20067:02 amRNSPreliminary Results
27th Feb 200610:06 amRNSPositive Preclinical Data
10th Feb 200611:49 amRNSHolding(s) in Company
12th Dec 20051:32 pmRNSHolding(s) in Company
15th Nov 20055:28 pmRNSHolding(s) in Company
15th Nov 200511:34 amRNSHolding(s) in Company
15th Nov 200511:31 amRNSHolding(s) in Company
15th Nov 200511:23 amRNSHolding(s) in Company
14th Nov 20057:01 amRNSChange of Adviser
9th Nov 200512:40 pmRNSResult of EGM
28th Oct 20053:09 pmRNSDirector/PDMR Shareholding
25th Oct 20057:02 amRNSBusiness Development Appt.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.